ArticleBone marrow transplantation2025

The 2023 EBMT report on hematopoietic cell transplantation and cellular therapies. Increased use of allogeneic HCT for myeloid malignancies and of CAR-T at the expense of autologous HCT.

Jakob R Passweg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.